Table 2.
Plasma OPN and MMP9, and serum hsCRP by metabolic syndrome criteria and by genotype
|
-MetS (n = 26) |
+MetS (n = 46) |
|||
|---|---|---|---|---|
| OPN, ug/L | 63±40 | 70±42 | ||
| MMP9, ug/L | 6.2±3.0 | 7.9±3.2† | ||
| hsCRP, mg/L | 2.5±4.2 | 8.9±10.0* | ||
|
TT (n = 15) |
TG & GG (n=11) |
TT (n = 28) |
TG & GG (n = 18) |
|
|---|---|---|---|---|
| OPN, ug/L | 58±26 | 69±54 | 68±38 | 74±49 |
| MMP9, ug/L | 5.9±2.6 | 6.5±3.6 | 7.8±3.5 | 8.2±2.7 |
| hsCRP, mg/L | 3.1±4.9 | 1.7±2.9 | 7.8±8.6 | 10.6±12.1 |
Data are expressed as mean±standard deviation. p values reflect significance after age- and gender-adjustment.
*
p ≤ 0.0001
†
p < 0.005 vs. -MetS.
hsCRP, high-sensitivity C-reactive protein; MMP9, matrix metalloproteinase 9; OPN, Osteopontin.